Message Font: Serif | Sans-Serif
No. of Recommendations: 0
Replying for Fuma - making this thread easier to find.

Someone wiser than me said the following:
"Dr Watson said: "Clostridium difficile costs Europe £1billion a year in healthcare costs. You could view that as saved money or saved beds.""

I think that is a hugely inflated number, and I dont believe there is a vaccine on the horizon that will be heavily used in the US within the next 5-8 years.... however, I do believe that the actual amount spent on antibiotic treatment warrants a market value higher than OPTR is fetching.

what OPTR, or any other CDiff mab maker does NOT need is this: some ICU journal making recommendations against their use the way that the American Diabetes Association recommended against using new agents like Byetta. If an ICU journal puts out a strong rec for it, and an ICU has good results after using it, the medical/surgical floors will soon follow. Its going to be awhile, but just a year ago consider what JPG wrote:

"We haven't had an ICU death in over 6 months since we started giving high dose vanco early and enterally. " ( now, there are numerous reported cases of vanco resistant cdiff.

Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.